Management of Hepatitis C/HIV Coinfection in the Era of Highly Effective Hepatitis C Virus Direct-Acting Antiviral Therapy: Table 1.

Pharmacologic Considerations in the Treatment of Hepatitis C Virus in Persons With HIV

(2016) Christine E. MacBrayne et al.   CLINICAL INFECTIOUS DISEASES

Long-Term Treatment Outcomes of Patients Infected With Hepatitis C Virus: A Systematic Review and Meta-analysis of the Survival Benefit of Achieving a Sustained Virological Response

(2015) Bryony Simmons et al.   CLINICAL INFECTIOUS DISEASES

Virologic Response Following Combined Ledipasvir and Sofosbuvir Administration in Patients With HCV Genotype 1 and HIV Co-infection

(2015) Anu Osinusi et al.   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Ombitasvir, Paritaprevir Co-dosed With Ritonavir, Dasabuvir, and Ribavirin for Hepatitis C in Patients Co-infected With HIV-1

(2015) Mark S. Sulkowski et al.   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Sofosbuvir plus ribavirin for treatment of hepatitis C virus in patients co-infected with HIV (PHOTON-2): a multicentre, open-label, non-randomised, phase 3 study

(2015) Jean-Michel Molina et al.   LANCET

Efficacy and safety of 12 weeks versus 18 weeks of treatment with grazoprevir (MK-5172) and elbasvir (MK-8742) with or without ribavirin for hepatitis C virus genotype 1 infection in previously untreated patients with cirrhosis and patients with previous null response with or without cirrhosis (C-WORTHY): a randomised, open-label phase 2 trial

(2015) Eric Lawitz et al.   LANCET

Ledipasvir and Sofosbuvir for HCV in Patients Coinfected with HIV-1

(2015) Susanna Naggie et al.   NEW ENGLAND JOURNAL OF MEDICINE

Daclatasvir plus Sofosbuvir for HCV in Patients Coinfected with HIV-1

(2015) David L. Wyles et al.   NEW ENGLAND JOURNAL OF MEDICINE

Efficacy and safety of grazoprevir (MK-5172) and elbasvir (MK-8742) in patients with hepatitis C virus and HIV co-infection (C-EDGE CO-INFECTION): a non-randomised, open-label trial

(2015) Jürgen K Rockstroh et al.   Lancet HIV

Causes of death among HIV-infected patients in France in 2010 (national survey)

(2014) Philippe Morlat et al.   AIDS

Hepatic Decompensation in Patients With HIV/Hepatitis B Virus (HBV)/Hepatitis C Virus (HCV) Triple Infection Versus HIV/HCV Coinfection and the Effect of Anti-HBV Nucleos(t)ide Therapy

(2014) Vincent Lo Re et al.   CLINICAL INFECTIOUS DISEASES

ABT-450, Ritonavir, Ombitasvir, and Dasabuvir Achieves 97% and 100% Sustained Virologic Response With or Without Ribavirin in Treatment-Experienced Patients With HCV Genotype 1b Infection

(2014) Pietro Andreone et al.   GASTROENTEROLOGY

Global distribution and prevalence of hepatitis C virus genotypes

(2014) Jane P. Messina et al.   HEPATOLOGY

Sofosbuvir and Ribavirin for Hepatitis C in Patients With HIV Coinfection

(2014) Mark S. Sulkowski et al.   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Trends in underlying causes of death in people with HIV from 1999 to 2011 (D:A:D): a multicohort collaboration

(2014) Colette J Smith et al.   LANCET

Retreatment of HCV with ABT-450/r–Ombitasvir and Dasabuvir with Ribavirin

(2014) Stefan Zeuzem et al.   NEW ENGLAND JOURNAL OF MEDICINE

Treatment of HCV with ABT-450/r–Ombitasvir and Dasabuvir with Ribavirin

(2014) Jordan J. Feld et al.   NEW ENGLAND JOURNAL OF MEDICINE

ABT-450/r–Ombitasvir and Dasabuvir with or without Ribavirin for HCV

(2014) Peter Ferenci et al.   NEW ENGLAND JOURNAL OF MEDICINE

ABT-450/r–Ombitasvir and Dasabuvir with Ribavirin for Hepatitis C with Cirrhosis

(2014) Fred Poordad et al.   NEW ENGLAND JOURNAL OF MEDICINE

Hepatitis C virus reinfection incidence and treatment outcome among HIV-positive MSM

(2013) Thomas C.S. Martin et al.   AIDS

Age at Cancer Diagnosis Among Persons With AIDS in the United States

(2013) Meredith S. Shiels et al.   ANNALS OF INTERNAL MEDICINE

HIV, Age, and the Severity of Hepatitis C Virus–Related Liver Disease

(2013) Gregory D. Kirk et al.   ANNALS OF INTERNAL MEDICINE

HIV/Hepatitis C Virus-Coinfected Patients and Cirrhosis: How to Diagnose It and What to Do Next?

(2013) V. Martel-Laferriere et al.   CLINICAL INFECTIOUS DISEASES

Antiretroviral Therapy Reduces the Rate of Hepatic Decompensation Among HIV- and Hepatitis C Virus–Coinfected Veterans

(2013) Jeffrey P. Anderson et al.   CLINICAL INFECTIOUS DISEASES

Decreasing mortality and changing patterns of causes of death in the Swiss HIV Cohort Study

(2013) R Weber et al.   HIV MEDICINE

Does an Index Composed of Clinical Data Reflect Effects of Inflammation, Coagulation, and Monocyte Activation on Mortality Among Those Aging With HIV?

(2012) A. C. Justice et al.   CLINICAL INFECTIOUS DISEASES

Treatment of acute hepatitis C virus infection in HIV-infected MSM: the effect of treatment duration

(2011) Femke AE Lambers et al.   AIDS

Projected life expectancy of people with HIV according to timing of diagnosis

(2011) Fumiyo Nakagawa et al.   AIDS

Management of hepatocellular carcinoma: An update

(2011) Jordi Bruix et al.   HEPATOLOGY

All-cause mortality in treated HIV-infected adults with CD4 >=500/mm3 compared with the general population: evidence from a large European observational cohort collaboration 

(2011) et al.   INTERNATIONAL JOURNAL OF EPIDEMIOLOGY

Comorbidity-Related Treatment Outcomes among HIV-Infected Adults in the Bronx, NY

(2011) Carolyn Chu et al.   JOURNAL OF URBAN HEALTH-BULLETIN OF THE NEW YORK ACADEMY OF MEDICINE

Hepatitis C Prevalence Among HIV-Positive MSM in San Francisco: 2004 and 2008

(2010) H. Fisher Raymond et al.   SEXUALLY TRANSMITTED DISEASES

Factors Associated with Prevalent Hepatitis C Infection Among HIV-Infected Women with No Reported History of Injection Drug Use: The Women's Interagency HIV Study (WIHS)

(2009) Toni Frederick et al.   AIDS PATIENT CARE AND STDS

Now there are many (stages) where before there was one: In search of a pathophysiological classification of cirrhosis

(2009) Guadalupe Garcia-Tsao et al.   HEPATOLOGY